Low dose resveratrol ameliorates mitochondrial respiratory dysfunction and enhances cellular reprogramming

Yuki Mizuguchi; Hideyuki Hatakeyama; Kou Sueoka; Mamoru Tanaka; Yu-ichi Goto

doi:10.1016/j.mito.2016.12.006

ScienceGate Book Chapters

JOURNAL ARTICLE

Low dose resveratrol ameliorates mitochondrial respiratory dysfunction and enhances cellular reprogramming

Yuki Mizuguchi Hideyuki Hatakeyama Kou Sueoka Mamoru Tanaka Yu-ichi Goto

Year: 2017 Journal: Mitochondrion Vol: 34 Pages: 43-48 Publisher: Elsevier BV

DOI: 10.1016/j.mito.2016.12.006

Get Full-Text PDF Get Analytical Report

Keywords:

Heteroplasmy Reprogramming Mitochondrial DNA Mitochondrial disease Induced pluripotent stem cell Mitochondrion Biology Resveratrol Respiratory chain Pharmacology Genetics Cell Gene

Metrics

Cited By

2.41

FWCI (Field Weighted Citation Impact)

Refs

0.86

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Mitochondrial Function and Pathology

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

CRISPR and Genetic Engineering

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Sirtuins and Resveratrol in Medicine

Health Sciences → Medicine → Geriatrics and Gerontology

Low dose resveratrol ameliorates mitochondrial respiratory dysfunction and enhances cellular reprogramming

Metrics

Citation History

Topics

Related Documents

Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming

Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock

Resveratrol-Encapsulated Mitochondria-Targeting Liposome Enhances Mitochondrial Respiratory Capacity in Myocardial Cells

Inhibition of ATPIF1 Ameliorates Severe Mitochondrial Respiratory Chain Dysfunction in Mammalian Cells

Macrophage metabolic reprogramming ameliorates diabetes-induced microvascular dysfunction